{
  "ticker": "LLY",
  "target_date": "2025-12-08",
  "actual_date": "2025-12-08",
  "collected_at": "2025-12-08T12:37:47.257709",
  "price": {
    "open": 1010.74,
    "high": 1014.2,
    "low": 989.0,
    "close": 993.6950073242188,
    "volume": 1444569,
    "change_1d_pct": -1.64,
    "change_7d_pct": -10.02,
    "change_30d_pct": 20.56
  },
  "technicals": {
    "rsi_14": 43.55,
    "sma_20": 1036.78,
    "sma_50": 916.06,
    "macd": 32.085,
    "macd_signal": 47.386,
    "macd_histogram": -15.301,
    "bb_upper": 1110.05,
    "bb_lower": 963.51,
    "price_vs_sma20_pct": -4.16,
    "price_vs_sma50_pct": 8.47,
    "volume_ratio": 0.38
  },
  "fundamentals": {
    "market_cap": 890804633600,
    "pe_ratio": 48.686672,
    "forward_pe": 43.852383,
    "price_to_book": 37.413216,
    "price_to_sales": 14.991714,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.64,
    "pct_from_52w_low": 59.3
  },
  "macro": {
    "spy": {
      "price": 682.79,
      "change_1d_pct": -0.42,
      "change_7d_pct": -0.09
    },
    "vix": {
      "level": 16.94,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.17
    },
    "dollar_index": {
      "level": 99.17
    },
    "gold": {
      "price": 4219.5
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Neuroblastoma Market - A Global and Regional Analysis: Focus on Treatment and Regional Analysis - Analysis and Forecast, 2025-2035",
      "source": "Yahoo",
      "datetime": 1765211640,
      "summary": "Neuroblastoma, a rare cancer mainly affecting children, is witnessing advancements in treatments, notably through immunotherapy, which has improved survival rates. Key innovations like gene and CAR-T cell therapies are accelerated by substantial government and private investments, transforming marke",
      "url": "https://finnhub.io/api/news?id=ebdc8fd5dab3867ccdd9efefafb38528db2a282a5d6f87c00bee7300fe39c687"
    },
    {
      "headline": "Structure Therapeutics Soars; CEO Says It Could Have 'Best-In-Class' Weight-Loss Drug",
      "source": "Yahoo",
      "datetime": 1765209306,
      "summary": "Structure Therapeutics said Monday patients who took its obesity treatment lost up to 15.3% more body weight than placebo recipients.",
      "url": "https://finnhub.io/api/news?id=2f126baa017c5a241833249d4e52353b481b6ae97d277bcbafc9343fc3bf9cfc"
    },
    {
      "headline": "Structure Therapeutics Stock Jumps on Trial Results for Weight-Loss Pill",
      "source": "Yahoo",
      "datetime": 1765208196,
      "summary": "Shares of Structure Therapeutics surged Monday after the biotechnology company said an experimental pill helped people lose substantial weight in a mid-stage clinical trial.  The trial results raised hopes for high sales in the booming obesity-drug market.  Analysts said the efficacy could make Stru",
      "url": "https://finnhub.io/api/news?id=ca858efcf0522f94ea4933ff29e1bee97eecd9257c85ca7c3b03582967afdecf"
    },
    {
      "headline": "Carolyn Bertozzi returns to Lilly board of directors",
      "source": "Yahoo",
      "datetime": 1765206000,
      "summary": "The board of directors of Eli Lilly and Company (NYSE: LLY) elected Carolyn R. Bertozzi, Ph.D., as a returning member, effective Dec. 8, 2025. She will serve on the board's Science and Technology and Ethics and Compliance committees.",
      "url": "https://finnhub.io/api/news?id=2d1293ad96aa9b58da965f0377e9536e15e984e72fa016ce9fc0ebc4c87df7c8"
    },
    {
      "headline": "Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term",
      "source": "Yahoo",
      "datetime": 1765205104,
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=856b23975e3a3576f6d7ff6beaf6b341631e4e200930d31781579b7f47884a2c"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}